Almirall, a global pharmaceutical leader specializing in medical dermatology, has embarked on a transformative three-year collaboration with Microsoft. The primary objective of this strategic alliance is to propel Almirall’s digital transformation and bolster its research endeavors in medical solutions, particularly focusing on dermatological diseases.
The cornerstone of this partnership involves the establishment of a collaborative digital office, dedicated to elevating Almirall’s existing unified data platform. Leveraging Microsoft’s generative artificial intelligence capabilities, the initiative aims to revolutionize the research landscape, driving advancements in medical solutions for dermatological ailments.
As part of the collaboration, Almirall is set to implement an innovative technology-supported data management model. This model is designed to optimize data access through robust data governance and digital identity management practices. The integration of such technological advancements positions Almirall on a trajectory to redefine dermatological treatments and strengthen its foothold as a pioneering force in the pharmaceutical domain.
Alberto Granados, President of Microsoft Spain, expressed the significance of the strategic alliance, stating, “Through this strategic alliance, Microsoft and its industry solutions organization will collaborate with Almirall in its goal of becoming the largest dermatology company of all time, revolutionizing dermatological treatments and offering patients the best possible solutions by leveraging cutting-edge technologies from Microsoft.”